H.R. 1143 · 119th Congress · House

Medicare IVIG Access Enhancement Act of 2025

Active· Introduced in House
Introduced
Feb 7, 25
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Medicare IVIG Access Enhancement Act of 2025

This bill provides for Medicare coverage of in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy (CIDP) or multifocal motor neuropathy. (CIDP is an autoimmune condition that causes symptoms such as muscle weakness and numbness; multifocal motor neuropathy is a variant of CIDP that only causes asymmetric muscle weakness.)

Action Timeline

2
  1. FEB 07, 2025•House floor actions

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  2. FEB 07, 2025•Library of Congress

    Introduced in House

Committees

2

Ways and Means Committee

hswm00

Referred: Feb 7, 2025

Active

Energy and Commerce Committee

hsif00

Referred: Feb 7, 2025

Active